Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,956 public trials 1,252 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Exelixis Clinical Site #53 Gilbert, Arizona, United States
  • Exelixis Clinical Site #18 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Duarte, California, United States
  • Exelixis Clinical Site #20 La Jolla, California, United States
View all 124 locations
View Trial Details
Active, Not Recruiting

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

NCT04046133

Conditions
Anal Cancer Stage III A, Anal Cancer Stage III B, Anus Diseases, +12 more
Locations
  • Oslo University Hospital Oslo, Norway
  • Aberdeen Royal Informary Aberdeen, Scotland, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
View Trial Details
Active, Not Recruiting

Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

NCT05444491

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Cancer hospital Chinese academy of medical sciences Beijing, Beijing Municipality, China
  • West China Hospital Chengdu, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • The Second Affiliated Hospital of Harbin Medical University Haerbin, China
View Trial Details
Active, Not Recruiting

Aspirin in Colorectal Cancer Liver Metastases

NCT03326791

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Cancer Liver Metastases, +11 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet, Copenhagen Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • Haukeland University Hospital Bergen, Norway
View all 14 locations
View Trial Details
Active, Not Recruiting

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

NCT06866574

Conditions
Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
Locations
  • Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
  • Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
  • Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
  • Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China
View Trial Details

Related conditions